Scott Tabakin
PRA GROUPAbout Scott M. Tabakin
Scott M. Tabakin is an independent director of PRA Group with deep CFO experience across public healthcare companies and earlier tenure at EY. He holds a B.S. in Accounting from the University of Illinois, is identified as age 63 in the 2025 proxy, and is considered independent under Nasdaq/SEC standards. His committee work includes leadership of the Board’s Risk Committee and membership on the Audit Committee, with the proxy identifying him as serving on Nominating and Corporate Governance as well. The Board reported all directors met at least 75% attendance in 2024 and all non-employee directors of 5+ years met ownership guidelines .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Value Options, Inc. (acquired by Anthem) | EVP & CFO | Not disclosed | Executive finance leadership |
| Bravo Health, Inc. (acquired by Cigna) | EVP & CFO | Not disclosed | Executive finance leadership |
| AMERIGROUP Corporation (NYSE; acquired by Anthem) | EVP & CFO | Not disclosed | Executive finance leadership |
| Beverly Enterprises, Inc. (NYSE; now Golden Gate National Senior Care) | EVP & CFO | Not disclosed | Executive finance leadership |
| Ernst & Young LLP | Executive | Not disclosed | Public accounting/assurance background |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Public company directorships | None | — | — |
Board Governance
| Attribute | Details |
|---|---|
| Independence | Board determined Tabakin and other listed directors are independent under Nasdaq/SEC rules as of the record date . |
| Attendance | Board met 11 times in 2024; each director attended at least 75% of Board and committee meetings; all directors attended the 2024 Annual Meeting . |
| Committee assignments (2025) | Risk Committee (Chair) and Audit Committee (member) per committee rosters; his director bio also lists Nominating & Corporate Governance membership . |
| Committee activity levels (2024) | Audit: 8 meetings; Compensation: 6; Nominating & Corporate Governance: 6; Risk: 6 . |
| Audit committee financial expert | Each Audit Committee member is designated an “audit committee financial expert” under the Exchange Act . |
| Related-party oversight | Nominating & Corporate Governance oversees the Related Party Transaction Policy; no related-party transactions in 2024 . |
| Hedging/Pledging | Company prohibits director hedging and pledging of company stock . |
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Board cash retainer (2024) | $70,000 | Annual cash retainer for Board members . |
| Committee member retainers (2024) | $15,000 each | Audit/Comp/NCG/Risk (members) . |
| Committee Chair retainers (2024) | $30,000 each | Audit, Compensation, NCG, Risk (chair receives chair retainer only) . |
| Lead Independent Director (2024) | $30,000 | Additional annual retainer . |
| Director (2024) | Cash Fees | Stock Awards | Total |
|---|---|---|---|
| Scott M. Tabakin | $115,000 | $154,991 | $269,991 |
Notes
- The 2024 non-employee director equity award was granted as RSUs valued at approximately $155,000, vesting on the first anniversary or earlier at the next annual meeting; 2024 grant date closing price reference $19.83 (June 13, 2024) .
Performance Compensation
| Element | Structure | Metrics | Vesting |
|---|---|---|---|
| Non-employee director equity | Time-based RSUs | None (no performance conditions) | Vest on anniversary or earlier at next annual meeting after grant . |
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | None . |
| Interlocks/conflicts | None disclosed; Related Party Transaction Policy requires NCG approval; no related party transactions in 2024 . |
Expertise & Qualifications
| Qualification | Evidence |
|---|---|
| Financial leadership | Former EVP/CFO at multiple large public healthcare companies; CPA background . |
| Regulatory/oversight | Skills listed include Government & Regulatory and Risk Oversight . |
| Public company acumen | Skill area explicitly noted; member of Audit Committee designated as financial expert per Exchange Act . |
| Strategic planning | Skill area explicitly noted . |
Equity Ownership
| Holder | Beneficial Ownership (shares) | Notes |
|---|---|---|
| Scott M. Tabakin | 87,258 | Includes RSUs vesting within 60 days of April 21, 2025; “less than 1%” of class applies to individuals . |
Director Stock Ownership Guidelines and Alignment
- Directors must own shares valued at ≥5x annual Board cash retainer within 5 years; as of April 21, 2025, all non-employee directors with ≥5 years of service met the guideline .
- Hedging and pledging are prohibited, supporting alignment and risk control .
Insider Transactions (Form 4)
| Date (Transacted) | Type | Shares | Price | Post-Transaction Holdings | Source |
|---|---|---|---|---|---|
| 2023-05-17 | Open market purchase | 12,000 | $19.07 | 72,894 | https://www.sec.gov/Archives/edgar/data/1185348/000122487723000002/0001224877-23-000002-index.htm |
| 2023-06-13 | Award (RSUs/Common) | 6,548 | $0 | 79,442 | https://www.sec.gov/Archives/edgar/data/1185348/000122487723000004/0001224877-23-000004-index.htm |
| 2024-06-13 | Award (RSUs/Common) | 7,816 | $0 | 87,258 | https://www.sec.gov/Archives/edgar/data/1185348/000122487724000001/0001224877-24-000001-index.htm |
| 2025-06-17 | Award (RSUs/Common) | 10,741 | $0 | 97,999 | https://www.sec.gov/Archives/edgar/data/1185348/000122487725000002/0001224877-25-000002-index.htm |
Ownership/Insider Implications
- The open-market buy in May 2023 is a positive alignment signal; subsequent annual RSU awards match the director program structure and scheduled grant cycles (SEC Form 4 URLs above).
Compensation Structure Analysis
| Year | Cash ($) | Equity ($ FV) | Total ($) |
|---|---|---|---|
| 2022 | 99,375 | 154,995 | 254,370 |
| 2024 | 115,000 | 154,991 | 269,991 |
- Mix and shifts: Cash increased from $99,375 (2022) to $115,000 (2024), while equity remained flat ($155k grant-date value); structure remains primarily fixed cash + time-based RSUs; no options or performance-linked director equity disclosed .
- Program features: No director perquisites or retirement benefits; D&O insurance maintained .
Governance Assessment
-
Strengths
- Experienced financial operator and CPA with multiple CFO tours; serves as Risk Committee Chair and Audit Committee member, supporting strong risk and financial oversight .
- Independence affirmed; attendance threshold met; director ownership guideline achieved for long-tenured directors; hedging/pledging prohibited .
- Related-party controls in place; none reported in 2024 .
-
Watch items
- Director-level disclosure provides only ≥75% attendance (no individual attendance detail) .
- Committee membership disclosures show slight inconsistencies between roster chart and bio (bio lists Nominating & Corporate Governance for Tabakin while roster lists other members); rely on roster for 2025 composition and note bio reference .
Overall, Tabakin’s finance-heavy background, Audit/Risk roles, and insider open-market purchase in 2023 support investor confidence in board oversight and alignment; no red flags surfaced in related-party transactions, hedging/pledging, or director pay structure .